Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. KIMS-Kingsway Hospitals

Verified

Basic Information

Site Overview

Source: Human-provided.

KIMS-Kingsway Hospitals is a multi-speciality tertiary care hospital in Nagpur, Maharashtra, India, originally established and operated by SPANV Medisearch Lifesciences Pvt. Ltd. and later taken over (majority stake) by the Krishna Institute of Medical Sciences (KIMS) Hospitals group. The facility has 300+ beds and serves as a key healthcare provider in central India, offering comprehensive medical services across numerous specialties including cardiology, neurology, orthopaedics, nephrology, urology, paediatrics, obstetrics & gynaecology, emergency and critical care, oncology, and more. It features advanced infrastructure such as 80+ critical care beds, multiple high-end operation theatres, a cath lab, and state-of-the-art diagnostic services to support tertiary care and complex procedures. The hospital combines technology with compassionate care, hosting experienced clinicians and diagnostic facilities for personalised treatments and preventive health programs. Situated near…

Source: Trial-derived.
16Total Trials
Source: Trial-derived.
6Recruiting Trials
Source: Trial-derived.
11Active Trials
Source: Trial-derived.
5Completed Trials
Source: Trial-derived.
15Unique Conditions
Source: Trial-derived.
15Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Atherosclerotic Cardiovascular Disease (ASCVD) (2)Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. Sickle Cell Disease (2)Source: Trial-derived. Ulcerative Colitis (2)Source: Trial-derived. Amyotrophic Lateral Sclerosis (1)Source: Trial-derived. Beta-Thalassemia (1)Source: Trial-derived. Chronic Kidney Disease (CKD) (1)Source: Trial-derived. Elevated Lp(a) (1)

Sponsors

Source: Trial-derived. Eli Lilly and Company (4)Source: Trial-derived. Tolmar Inc. (2)Source: Trial-derived. Abivax S.A. (1)Source: Trial-derived. Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA (1)Source: Trial-derived. Aurigene Discovery Technologies Limited (1)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Celgene (1)Source: Trial-derived. Genentech, Inc. (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 28

Principal investigators

Source: Human-provided. 10

Study coordinators

Source: Human-provided. 10

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Endoscopy / colonoscopy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot